Skyline Shanghai
Biotech

Could we see 10 Chinese Big Pharmas within a decade?

Fierce spoke to a range of Chinese biopharma CEOs to understand their plans to go global—and why their time could be fast approaching.
Leslie Zhen Liang Nov 11, 2026 9:00am
akt health

Why scientific progress depends on knowing when to look again

Brought to you by Ipsen
Blackstone

Pfizer taps Blackstone for $1.5B to pave path to GLP-1 launch

Nov 12, 2026 4:15am
Advanced Analytics Help Reduce Control Animal Use While Preserving Scientific Rigor

How Virtual Control Groups Are Shaping Safety Studies

Brought to you by Charles River Laboratories
fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: Eli Radiopharma & more

Nov 12, 2026 4:00am
cash money

Addex spinout raises $105M series B for schizophrenia ph. 2

Nov 12, 2026 3:56am
More News

Flagship AI-based biotechs Valo, Montai tie the knot

Nov 11, 2026 2:30pm

Rivia launches AI-powered clinical trial data review

Nov 11, 2026 1:00pm
Fierce Pharma

BioNTech pays $205M for FDA voucher to speed up cancer pipeline

Nov 11, 2026 8:20am

Amgen posts ph. 3 Sjögren’s data ahead of Novartis showdown

Nov 11, 2026 8:00am